1015-P: Effects of the Oral, Small Molecule GLP-1R Agonist TTP273 on Patients With Stage 2 Hypertension: Results From a Post Hoc Analysis of the Phase 2 Logra Study

Diabetes - United States
doi 10.2337/db19-1015-p
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association


Related search